Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Intensive care infection score: ICIS discriminates between infected and uninfected critically ill patients in routine intensive care unit practice

View through CrossRef
Abstract Background Diagnosis of infectious inflammation is challenging as acute phase protein expression is nonspecific, limiting the utility of well-established biomarkers, such as procalcitonin (PCT) and C-reactive protein (CRP). The emergent blood cell-derived Intensive Care Infection Score (ICIS) is an innovative approach for the sensitive and specific diagnosis of infection in intensive care unit (ICU) patients. This study aimed to confirm the suitability of routine ICIS use in various ICU settings. Methods This retrospective study included 115 patients from three ICUs. Seventy-five patients were diagnosed as infected and 40 as uninfected. ICIS, CRP, and PCT were compared to routine clinical assessment to evaluate their effectiveness in predicting infection in critically ill patients. Results ICIS was superior to CRP and PCT in discriminating infection from no infection on day 1 in the ICU. In receiver operating characteristic curve analysis, ICIS exhibited an AUC = 0.984, sensitivity of 90.7%, specificity of 97.5%, positive predictive value (PPV) of 97.7% and negative predictive value (NPV) of 89.9%, by the best cutoff value of 3. CRP gave an AUC = 0.727, PPV of 70.0% and NPV of 67.8% by best cutoff value of 8.3 mg/L with a sensitivity of 74.7% and specificity of 62.5%. The best cutoff value of 0.9 ng/mL was calculated for PCT with an AUC = 0.812, PPV of 84.4%, NPV of 70.3%, sensitivity of 69.3% and specificity of 85.0%. Conclusions ICIS outperformed CRP and PCT in identifying infection in critically ill patients across different ICU settings on the first day in the ICU. The high NPV emphasizes the potential of ICIS as an adjuvant tool to rule out infections thereby facilitating the reduction of antibiotic overuse and consequently limiting antimicrobial resistance (AMR) development. ICIS appears suitable for routine implementation in various ICU settings. Graphical Abstract
Title: Intensive care infection score: ICIS discriminates between infected and uninfected critically ill patients in routine intensive care unit practice
Description:
Abstract Background Diagnosis of infectious inflammation is challenging as acute phase protein expression is nonspecific, limiting the utility of well-established biomarkers, such as procalcitonin (PCT) and C-reactive protein (CRP).
The emergent blood cell-derived Intensive Care Infection Score (ICIS) is an innovative approach for the sensitive and specific diagnosis of infection in intensive care unit (ICU) patients.
This study aimed to confirm the suitability of routine ICIS use in various ICU settings.
Methods This retrospective study included 115 patients from three ICUs.
Seventy-five patients were diagnosed as infected and 40 as uninfected.
ICIS, CRP, and PCT were compared to routine clinical assessment to evaluate their effectiveness in predicting infection in critically ill patients.
Results ICIS was superior to CRP and PCT in discriminating infection from no infection on day 1 in the ICU.
In receiver operating characteristic curve analysis, ICIS exhibited an AUC = 0.
984, sensitivity of 90.
7%, specificity of 97.
5%, positive predictive value (PPV) of 97.
7% and negative predictive value (NPV) of 89.
9%, by the best cutoff value of 3.
CRP gave an AUC = 0.
727, PPV of 70.
0% and NPV of 67.
8% by best cutoff value of 8.
3 mg/L with a sensitivity of 74.
7% and specificity of 62.
5%.
The best cutoff value of 0.
9 ng/mL was calculated for PCT with an AUC = 0.
812, PPV of 84.
4%, NPV of 70.
3%, sensitivity of 69.
3% and specificity of 85.
0%.
Conclusions ICIS outperformed CRP and PCT in identifying infection in critically ill patients across different ICU settings on the first day in the ICU.
The high NPV emphasizes the potential of ICIS as an adjuvant tool to rule out infections thereby facilitating the reduction of antibiotic overuse and consequently limiting antimicrobial resistance (AMR) development.
ICIS appears suitable for routine implementation in various ICU settings.
Graphical Abstract.

Related Results

Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Biomarkers in critically ill patients
Biomarkers in critically ill patients
We investigated whether biomarkers could (1) improve early diagnosis of sepsis (2) predict prognosis in patients with pneumonia and aneurysmal subarachnoid hemorrhage, (3) predict ...
Hematopoietic Stem Cell Infected with HTLV-1 Functions As a Viral Reservoir In Vivo
Hematopoietic Stem Cell Infected with HTLV-1 Functions As a Viral Reservoir In Vivo
Abstract Human T-cell leukemia virus type 1 (HTLV-1) is a causative agent of a malignant disease of peripheral CD4+ T cells called adult T-cell leuke...
Pet Euthanasia and Human Euthanasia
Pet Euthanasia and Human Euthanasia
Photo ID 213552852 © Yuryz | Dreamstime.com Abstract A criticism of assisted death is that it’s contrary to the Hippocratic Oath. This opposition to assisted death assumes that dea...
Identification of TGFBR2 mutation as a negative predictor of immunotherapy in NSCLC.
Identification of TGFBR2 mutation as a negative predictor of immunotherapy in NSCLC.
e21002 Abstract Background: Immune adaptive resistance is one of the reasons contributing to the resistance of immune checkpoint inhibitors (ICIs). Previous studies have demonstra...

Back to Top